These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 38823417

  • 1. Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?
    Rotvig DH, Jorgensen A, Jensen JH, Hansen AR, Eller NH, Jonsson SH, Knorr U, Klose MC, Feldt-Rasmussen U, Menke A, Poulsen HE, Bauer JØ, Jørgensen MB.
    Stress; 2024 Jan; 27(1):2353781. PubMed ID: 38823417
    [Abstract] [Full Text] [Related]

  • 2. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS, Cetinkalp S, Tunay S, Polat I, Simsek F, Aksoy B, Kizilates G, Erdogan Y, Coburn KL.
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [Abstract] [Full Text] [Related]

  • 3. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 4. Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression.
    Yokoyama K, Yamada T, Mitani H, Yamada S, Pu S, Yamanashi T, Matsumura H, Nakagome K, Kaneko K.
    Psychiatry Res; 2015 Apr 30; 226(2-3):494-8. PubMed ID: 25757913
    [Abstract] [Full Text] [Related]

  • 5. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.
    J Psychiatr Res; 2001 Apr 30; 35(4):239-47. PubMed ID: 11578642
    [Abstract] [Full Text] [Related]

  • 6. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 30; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 7. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 30; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 8. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W.
    Biol Psychiatry; 2002 Dec 01; 52(11):1102-12. PubMed ID: 12460693
    [Abstract] [Full Text] [Related]

  • 9. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 01; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 10. The dexamethasone corticotropin releasing hormone test in healthy and depressed women with and without childhood adversity.
    Spitzer C, Otte C, Kuehl LK, May A, Schultebraucks K, Hellmann-Regen J, Wingenfeld K.
    Psychoneuroendocrinology; 2018 Jan 01; 87():147-151. PubMed ID: 29080551
    [Abstract] [Full Text] [Related]

  • 11. HPA axis reactivity to pharmacologic and psychological stressors in euthymic women with histories of postpartum versus major depression.
    Ferguson EH, Di Florio A, Pearson B, Putnam KT, Girdler S, Rubinow DR, Meltzer-Brody S.
    Arch Womens Ment Health; 2017 Jun 01; 20(3):411-420. PubMed ID: 28251369
    [Abstract] [Full Text] [Related]

  • 12. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH, Siegrist J, Schuhmacher A, Hoefels S, Maier W, Zobel AW.
    Psychoneuroendocrinology; 2010 May 01; 35(4):536-43. PubMed ID: 19818562
    [Abstract] [Full Text] [Related]

  • 13. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls.
    Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH.
    Psychoneuroendocrinology; 2009 Sep 01; 34(8):1208-13. PubMed ID: 19375869
    [Abstract] [Full Text] [Related]

  • 14. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F.
    Psychoneuroendocrinology; 2017 Apr 01; 78():39-47. PubMed ID: 28167369
    [Abstract] [Full Text] [Related]

  • 15. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007 Apr 01; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.
    Psychoneuroendocrinology; 2016 Jul 01; 69():161-71. PubMed ID: 27107207
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug 01; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 18. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 19. The Cortisol and ACTH Response to Dex/CRH Testing in Women With and Without Perimenopausal Depression.
    Guerrieri GM, Ben Dor R, Li X, Wei SM, Martinez PE, Neiman LK, Rubinow DR, Schmidt PJ.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):3007-3018. PubMed ID: 34097071
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 27; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.